BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 33141330)

  • 21. Antiviral therapy improves post-operative survival outcomes in patients with HBV-related hepatocellular carcinoma of less than 3 cm - A retrospective cohort study.
    Wang ZY; Tao QF; Wang ZH; Lin KY; Huang G; Yang Y; Zhou WP; Lau WY
    Am J Surg; 2020 Apr; 219(4):717-725. PubMed ID: 31266631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma.
    Izumi R; Shimizu K; Iyobe T; Ii T; Yagi M; Matsui O; Nonomura A; Miyazaki I
    Hepatology; 1994 Aug; 20(2):295-301. PubMed ID: 8045490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma].
    Zhang Z; Wu M; Liu Q
    Zhonghua Zhong Liu Za Zhi; 1999 May; 21(3):214-6. PubMed ID: 11776840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency Ablation.
    Peng Z; Chen S; Wei M; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Chen M; Qian G; Kuang M
    Radiology; 2018 May; 287(2):705-714. PubMed ID: 29390197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic therapies for hepatocellular carcinoma.
    Ge S; Huang D
    Drug Discov Ther; 2015 Oct; 9(5):352-62. PubMed ID: 26632544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 27. Sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Japan.
    Ogasawara S; Ooka Y; Itokawa N; Inoue M; Okabe S; Seki A; Haga Y; Obu M; Atsukawa M; Itobayashi E; Mizumoto H; Sugiura N; Azemoto R; Kanayama K; Kanzaki H; Maruta S; Maeda T; Kusakabe Y; Yokoyama M; Kobayashi K; Kiyono S; Nakamura M; Saito T; Suzuki E; Nakamoto S; Yasui S; Tawada A; Chiba T; Arai M; Kanda T; Maruyama H; Kato N
    Invest New Drugs; 2020 Feb; 38(1):172-180. PubMed ID: 31172442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aggressive intrahepatic therapies for synchronous hepatocellular carcinoma with pulmonary metastasis.
    Hu Z; Huang P; Zhou Z; Li W; Xu J; Xu K; Wang J; Zhang H
    Clin Transl Oncol; 2018 Jun; 20(6):729-739. PubMed ID: 29110217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcomes after hepatectomy of huge hepatocellular carcinoma: A single-center experience in China.
    Fang Q; Xie QS; Chen JM; Shan SL; Xie K; Geng XP; Liu FB
    Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):532-537. PubMed ID: 31543313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatectomy combined with sorafenib in patients with intermediate-advanced hepatocellullar carcinoma.
    Zhu H; Ye B; Qiao Z; Zeng L; Li Q
    J BUON; 2019; 24(4):1382-1389. PubMed ID: 31646781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcatheter arterial chemoembolization combined with interferon-α is safe and effective for patients with hepatocellular carcinoma after curative resection.
    Zuo CH; Xia M; Liu JS; Qiu XX; Lei X; Xu RC; Liu HC; Li JL; Li YG; Li QL; Xiao H; Hong Y; Wang XH; Zhu HZ; Wu QF; Burns M; Liu C
    Asian Pac J Cancer Prev; 2015; 16(1):245-51. PubMed ID: 25640360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma.
    Peng Z; Chen S; Xiao H; Wang Y; Li J; Mei J; Chen Z; Zhou Q; Feng S; Chen M; Qian G; Peng S; Kuang M
    Radiology; 2019 Jul; 292(1):237-247. PubMed ID: 31135299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Application of adenosine triphosphate tumor chemosensitive assay system to individual chemotherapy for hepatocellular carcinoma].
    Chen T; Chu ZH; Liu JP; Wang J; Zhao HY; Ou QJ
    Ai Zheng; 2005 Aug; 24(8):1018-22. PubMed ID: 16086886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Survival analysis of patients with spontaneous rupture of hepatocellular carcinoma].
    Zhao GG; Xu W; Tian YH; Li DX
    Zhonghua Gan Zang Bing Za Zhi; 2012 Nov; 20(11):838-42. PubMed ID: 23206303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma.
    Tung-Ping Poon R; Fan ST; Wong J
    Ann Surg; 2000 Jul; 232(1):10-24. PubMed ID: 10862190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction and clinical significance of a predictive system for prognosis of hepatocellular carcinoma.
    Cui J; Dong BW; Liang P; Yu XL; Yu DJ
    World J Gastroenterol; 2005 May; 11(20):3027-33. PubMed ID: 15918184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does postoperative adjuvant transarterial chemoembolization benefit for all patients with hepatocellular carcinoma combined with microvascular invasion: a meta-analysis.
    Wang L; Ke Q; Lin N; Zeng Y; Liu J
    Scand J Gastroenterol; 2019 May; 54(5):528-537. PubMed ID: 31081401
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical efficacy and prognostic factors analysis following curative hepatectomy for hepatocellular carcinoma patients with different China Liver Cancer Staging].
    Li CX; Zhang H; Wu XF; Han S; Jiao CY; Wang D; Wang K; Li XC
    Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):134-143. PubMed ID: 33378806
    [No Abstract]   [Full Text] [Related]  

  • 39. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
    Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
    World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with peritoneal hepatocellular carcinoma.
    Tabrizian P; Franssen B; Jibara G; Sweeney R; Sarpel U; Schwartz M; Labow D
    J Surg Oncol; 2014 Dec; 110(7):786-90. PubMed ID: 25091997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.